A report by Precedence Research examines the cell culture media market size is predicted to hit around USD 16.84 billion by 2032 and is growing at a CAGR of 11.89% from 2023 to 2032.
A report by Precedence Research examines the cell culture media market size is predicted to hit around USD 16.84 billion by 2032 and is growing at a CAGR of 11.89% from 2023 to 2032.
A concentrated growth medium that supplies nutrients and controls cell development is known as a cell culture medium. The widespread use of cell culture media, the expansion of pharmaceutical industry research and development, the rising incidence of chronic diseases, and the expansion and increased product launches by major players are the primary factors driving market growth.
Get the report sample pages@ https://www.precedenceresearch.com/checkout/2847
Regional snapshots
The largest portion of the worldwide market for cell culture media was in North America. The large share is ascribed to the presence of major manufacturers, rising disease prevalence driving up demand for drugs and other medications, technological developments in the preclinical and clinical space, rising public awareness, and high disposable income. Therefore, during the projected time, market growth will be aided by this growing patient pool.
Due to the presence of numerous research institutions, cheap manufacturing and labour costs, growing healthcare infrastructure, and increased investments by American and European market titans in Asian nations like China and India, the Asia-Pacific region held the third-largest market share.
Market dynamics
Drivers
In order to control and promote the growth of cells or microorganisms used in the production of biopharmaceuticals, cell culture media is typically a gel or liquid. The fastest-growing subset of the cell culture market, culture media is a crucial component in the production of biopharmaceuticals because it promotes cell development. The quick expansion is primarily caused by the rising demand for biopharmaceuticals, supportive governmental regulations, and rising R&D expenditures.
Market trends in the cell culture media market:
- Serum-Free and Chemically Defined Media: There was a growing demand for serum-free and chemically defined cell culture media. These media types offer more consistent and defined conditions for cell growth, reducing the risk of contamination and variability compared to traditional serum-containing media.
- Animal Component-Free Media: Due to concerns about safety, ethical considerations, and regulatory requirements, there was an increasing push for animal component-free cell culture media. Manufacturers were developing media formulations that do not include any animal-derived components to ensure greater control and reproducibility.
- Customized and Specialty Media: Researchers and biopharmaceutical companies were seeking more specialized and tailored cell culture media formulations to meet the specific needs of their cell lines. This trend was driving the development of customizable and specialty media options.
- Xeno-Free Media: Xeno-free media are formulations that do not contain any components of animal origin. This trend was particularly significant in the context of stem cell culture and regenerative medicine, where researchers were striving to create safe and reliable cell culture systems for clinical applications.
- 3D Cell Culture Media: The use of three-dimensional (3D) cell culture models was becoming more prevalent as researchers recognized their ability to better mimic in vivo conditions. As a result, there was a growing need for specialized 3D cell culture media to support these advanced culture techniques.
- Biomanufacturing and Biopharmaceutical Production: The biopharmaceutical industry was adopting cell culture technologies for the production of biologics such as monoclonal antibodies, recombinant proteins, and vaccines. This trend was driving the demand for high-quality, scalable, and consistent cell culture media formulations.
- Advanced Cell Therapies: The field of cell-based therapies, including CAR-T cell therapy and other immunotherapies, was rapidly evolving. This required the development of specialized culture media to support the expansion and differentiation of therapeutic cell populations.
- Continuous Cell Culture Systems: Continuous cell culture systems were gaining attention as an alternative to traditional batch culture systems. These systems offer improved efficiency, reduced labor requirements, and higher yields, driving the need for media formulations optimized for continuous culture.
- Automation and High-Throughput Screening: Automation and high-throughput screening were becoming increasingly integrated into cell culture workflows. This trend prompted the development of media formulations that are compatible with automated platforms and facilitate rapid screening of conditions.
Restraints
High costs and media contamination are most likely to restrain market growth. The expense of the product is increased by the presence of serum and other animal components in the cell culture media. Market growth is impacted by the challenges of precision, variability, and standardisation. A significant danger to the market for cell culture media is the contamination of the media by serum and animal components obtained from subpar, unreliable sources. The limited technologies accessible for the production, preservation, and processing of different cell lines, including stem cells, embryonic cells, and others, are another hindrance to the market.
| Region | Revenue Share 2022 (%) |
| North America | 38% |
| Europe | 29% |
| Asia Pacific | 26% |
| Latin America | 4% |
| MEA | 3% |
Opportunities
Emerging nations like China, India, Brazil, and Mexico are anticipated to become the focus of growth in the global market during the forecast era. The main causes of this tendency include rising investments in cell biology research and a growing concentration on expanding market participants’ presence in developing Asian markets.
Challenges
It is a major challenge for small players and new entrants to survive in the global market. Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group AG (Switzerland), Sartorius AG (Germany), and Danaher Corporation (US) are well-established competitors that account for or hold a significant share of the industry. These competitors have a wide range of products and well-known brands. Additionally, these key players frequently buy up new competitors or start-ups to expand their product offerings in an effort to keep their competitive advantage. Given the dominance of the big players, it is difficult for newcomers and small players to compete in this industry.
Report highlights
Cell culture media is further divided into a variety of product types, including chemically defined media, stem cell media, serum free media, specialized media, and others. The section of serum-free media had the highest percentage in 2022. Serum-free media are a crucial tool for researchers because they allow them to grow a specific cell type or conduct out specific applications without the need for serum. By application, the industry was dominated in 2022 by the manufacturing of biopharmaceuticals. Additionally, the pharmaceutical and biopharmaceutical industry had the highest revenue share when broken down by final use. The development of current biopharmaceutical manufacturing capabilities is what is driving the demand for cell culture goods.
Recent developments
In February 2022 – To support business expansion in the cell culture media sector, Fujifilm Corporation (Japan) created a subsidiary in South Korea. High-quality cell culture media will be made available by this subsidiary for sophisticated gene and cell therapies as well as bio production.
Market Segmentation
By Product
- Serum-free Media
- CHO Media
- BHK Medium
- Vero Medium
- HEK 293 Media
- Others
- Classical Media
- Stem Cell Culture Media
- Specialty Media
- Chemically Defined Media
- Others
By Application
- Biopharmaceutical Production
- Monoclonal Antibodies
- Vaccines Production
- Others Therapeutic Proteins
- Diagnostics
- Drug Screening and Development
- Tissue Engineering and Regenerative Medicine
- Cell and Gene Therapy
- Others
By Type
- Liquid Media
- Semi-solid and Solid Media
By End-User
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostics Laboratories
- Research and Academic Institutes
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/2847
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333